Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and Adenocarcinoma Of Kidney

oxazoles has been researched along with Adenocarcinoma Of Kidney in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, N; Chen, Z; He, Q; Huang, Z; Jiang, H; Peng, D; Wan, P; Zhong, W1
Abu Aboud, O; Weiss, RH; Wettersten, HI1
Abu Aboud, O; Bultman, S; Donohoe, D; Fitch, M; Hellerstein, M; Riiff, T; Weiss, RH1
Abe, K; Fujiwara, J; Hayashi, I; Ishida, H; Kawauchi, A; Li, YN; Miki, T; Mizutani, Y; Nakanishi, H; Sato, N; Toiyama, D1
Carbone, PP; Davis, TE; Earle, JD; Elson, PJ; Glover, DJ; Hahn, RG; Kvols, LK; Trump, DL; Vogl, SE1

Other Studies

5 other study(ies) available for oxazoles and Adenocarcinoma Of Kidney

ArticleYear
BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
    Oncology reports, 2020, Volume: 44, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Renal Cell; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Kidney Neoplasms; Mice; Nuclear Proteins; Organic Chemicals; Oxazoles; Pyridines; Pyrroles; Xenograft Model Antitumor Assays

2020
Inhibition of PPARĪ± induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cells.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Apoptosis; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Deoxyglucose; G1 Phase; Glucose; Glycolysis; Humans; Immunoblotting; Immunohistochemistry; Kidney Neoplasms; Oxazoles; PPAR alpha; Proto-Oncogene Proteins c-myc; Resting Phase, Cell Cycle; RNA Interference; Tyrosine

2013
PPARĪ± inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth.
    American journal of physiology. Cell physiology, 2015, Jun-01, Volume: 308, Issue:11

    Topics: Animals; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Kidney Tubules; Metabolic Networks and Pathways; Mice; Mice, Nude; Organ Specificity; Oxazoles; Phosphorylation; PPAR alpha; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Signal Transduction; Tyrosine; Xenograft Model Antitumor Assays

2015
Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522.
    Urologia internationalis, 2010, Volume: 84, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Carcinoma, Renal Cell; Cyclooxygenase 2 Inhibitors; Drug Screening Assays, Antitumor; Humans; Kidney Neoplasms; Oxazoles; Tumor Cells, Cultured

2010
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.
    Investigational new drugs, 1988, Volume: 6, Issue:2

    Topics: Adult; Aged; Alanine; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Isoxazoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oxazoles; Thiadiazoles; Vinblastine

1988